Quick Answer
STERIS plc reported Total Revenue of $5.46 billion for fiscal year 2025.
STERIS plc — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.46B +6.2% |
$5.14B +13.3% |
$4.54B +7.4% |
$4.22B +35.9% |
$3.11B +2.5% |
$3.03B +8.9% |
| Net Income | $614.64M +62.5% |
$378.24M +253.4% |
$107.03M -56.1% |
$243.89M -38.6% |
$397.40M -2.5% |
$407.66M +34.2% |
| Diluted EPS | $6.20 +62.7% |
$3.81 +256.1% |
$1.07 -56.9% |
$2.48 -46.4% |
$4.63 -2.7% |
$4.76 +34.1% |
| Total Assets | $10.15B -8.3% |
$11.06B +2.2% |
$10.82B -5.3% |
$11.42B +73.8% |
$6.57B +20.8% |
$5.44B +7.2% |
| Cash and Equivalents | — | — | — | — | $220.53M -31.0% |
$319.58M +44.8% |
| Long-Term Debt | $1.92B -38.5% |
$3.12B +3.4% |
$3.02B +2.5% |
$2.95B +78.5% |
$1.65B +43.5% |
$1.15B -2.8% |
| Stockholders Equity | $6.60B +4.8% |
$6.30B +3.7% |
$6.08B -7.0% |
$6.53B +68.3% |
$3.88B +14.0% |
$3.41B +7.2% |
| R&D Expense | $107.65M +3.8% |
$103.68M +5.3% |
$98.48M +13.6% |
$86.66M +30.7% |
$66.33M +1.2% |
$65.55M +4.0% |
| Operating Income | $866.64M +3.7% |
$836.12M +5.7% |
$791.10M +65.6% |
$477.81M -12.9% |
$548.37M +2.1% |
$537.05M +30.7% |
| Gross Profit | $2.40B +8.3% |
$2.22B +12.0% |
$1.98B +5.2% |
$1.88B +40.2% |
$1.34B +1.8% |
$1.32B +12.3% |
| Shares Outstanding | 98.30M -0.6% |
98.88M +0.3% |
98.63M -1.4% |
100.07M +17.2% |
85.35M +0.5% |
84.92M +0.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $1.50B | +9.2% | +2.5% |
| Net Income | December 31, 2025 | $192.90M | +11.2% | +0.5% |
| Diluted EPS | December 31, 2025 | $1.96 | +12.0% | +1.0% |
| Total Assets | December 31, 2025 | $10.59B | +5.8% | +1.7% |
| Cash and Equivalents | December 31, 2025 | $423.70M | +173.0% | +32.7% |
| Long-Term Debt | December 31, 2025 | $1.90B | -6.9% | +0.1% |
| Stockholders Equity | December 31, 2025 | $7.15B | +11.5% | +2.1% |
| R&D Expense | December 31, 2025 | $29.50M | +7.7% | +4.6% |
| Operating Income | December 31, 2025 | $273.20M | +11.4% | +2.8% |
| Gross Profit | December 31, 2025 | $655.50M | +7.4% | +1.5% |
| Shares Outstanding | December 31, 2025 | 98.10M | -0.1% | +0.0% |
- STERIS plc reported Total Revenue of $5.46 billion for fiscal year 2025.
- STERIS plc showed an increase of +6.2% in Total Revenue compared to the prior fiscal year.
- STERIS plc reported Net Income of $614.64 million for fiscal year 2025.
- STERIS plc showed an increase of +62.5% in Net Income compared to the prior fiscal year.
- STERIS plc reported Diluted EPS of $6.20 per share for fiscal year 2025.
- STERIS plc showed an increase of +62.7% in Diluted EPS compared to the prior fiscal year.
- STERIS plc reported Total Assets of $10.15 billion for fiscal year 2025.
- STERIS plc showed a decrease of -8.3% in Total Assets compared to the prior fiscal year.
- STERIS plc reported Cash and Equivalents of $220.53 million for fiscal year 2021.
- STERIS plc showed a decrease of -31.0% in Cash and Equivalents compared to the prior fiscal year.
- STERIS plc reported Long-Term Debt of $1.92 billion for fiscal year 2025.
- STERIS plc showed a decrease of -38.5% in Long-Term Debt compared to the prior fiscal year.
- STERIS plc reported Stockholders Equity of $6.60 billion for fiscal year 2025.
- STERIS plc showed an increase of +4.8% in Stockholders Equity compared to the prior fiscal year.
- STERIS plc reported R&D Expense of $107.65 million for fiscal year 2025.
- STERIS plc showed an increase of +3.8% in R&D Expense compared to the prior fiscal year.
- STERIS plc reported Operating Income of $866.64 million for fiscal year 2025.
- STERIS plc showed an increase of +3.7% in Operating Income compared to the prior fiscal year.
- STERIS plc reported Gross Profit of $2.40 billion for fiscal year 2025.
- STERIS plc showed an increase of +8.3% in Gross Profit compared to the prior fiscal year.
- STERIS plc reported Shares Outstanding of 98.30 million shares for fiscal year 2025.
- STERIS plc showed a decrease of -0.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: